These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 6221548)
21. Effect of an oral thromboxane synthetase inhibitor (OKY-046) on antigen-induced bronchoconstriction in guinea pigs. Nambu F; Shiraji T; Motoishi M; Sawada M; Omawari N; Terashima H; Okegawa T; Kawasaki A; Ikeda S Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():528-30. PubMed ID: 2526531 [No Abstract] [Full Text] [Related]
22. [Kinetics of thromboxane A2 and prostacyclin during reperfusion after induced ischemia in canine hearts]. Nomura F; Hirose H; Matsuda H; Nakano S; Shirakura R; Ohtani M; Kaneko M; Sasako Y; Kawashima Y; Kuzuya T Kyobu Geka; 1985 Jan; 38(1):46-9. PubMed ID: 3884863 [No Abstract] [Full Text] [Related]
23. Prostacyclin and thromboxane A2 production by human cardiac atrial tissues. Mehta J; Mehta P Am Heart J; 1985 Jan; 109(1):1-3. PubMed ID: 3880988 [TBL] [Abstract][Full Text] [Related]
24. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581. Casey LC; Fletcher JR; Zmudka MI; Ramwell PW J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528 [TBL] [Abstract][Full Text] [Related]
25. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects. Morio H; Hirai A; Terano T; Tamura Y; Yoshida S Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052 [TBL] [Abstract][Full Text] [Related]
26. Endogenous biosynthesis of prostaglandin I2 and thromboxane A2 by isolated rat dental pulp. Hirafuji M; Ogura Y Biochem Pharmacol; 1983 Oct; 32(19):2983-5. PubMed ID: 6354192 [No Abstract] [Full Text] [Related]
27. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs. Murayama K; Kasai H; Adachi T; Utsunomiya O; Ouchi H Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):344-50. PubMed ID: 6339650 [TBL] [Abstract][Full Text] [Related]
28. Effects of OKY-046, a selective thromboxane A2 synthetase inhibitor, on ventricular arrhythmias and prostaglandins during coronary artery ligation and reperfusion in anesthetized dogs. Ogura T; Watanabe I; Saito T; Saito S; Ozawa Y; Hatano M Jpn J Pharmacol; 1988 May; 47(1):95-8. PubMed ID: 3411822 [TBL] [Abstract][Full Text] [Related]
29. [The effect of a thromboxane synthetase inhibitor in canine hemorrhagic shock]. Ooki H; Nomiyama S Masui; 1987 Nov; 36(11):1777-81. PubMed ID: 3446836 [No Abstract] [Full Text] [Related]
30. [Effect of OKY-046, a thromboxane synthetase inhibitor, on renal thromboxane synthesis in spontaneously hypertensive rat]. Nakayama D; Ikeda T Nihon Jinzo Gakkai Shi; 1988 Jan; 30(1):79-84. PubMed ID: 3386014 [No Abstract] [Full Text] [Related]
31. Clinical study on effect of thromboxane A2 synthetase inhibitor (OKY-046) to clarify the regulation of cerebral blood flow in cerebral thrombosis. Nihei C; Metoki H; Shimanaka Y; Kawahara R; Komatsu O; Oike Y; Kanazawa T; Izawa M; Kaneko H; Hoshi Y Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():953-7. PubMed ID: 2960210 [No Abstract] [Full Text] [Related]
32. Inhibition of thromboxane A2 synthesis by OKY-046 attenuates ischemia and reperfusion injury of the liver. Iida J; Shimamura T; Suzuki T; Jin MB; Taniguchi M; Fukai M; Yokota R; Horiuchi H; Magata S; Kishida A; Furukawa H; Todo S Transplant Proc; 1999; 31(1-2):1061-2. PubMed ID: 10083474 [No Abstract] [Full Text] [Related]